ASX Announcements



Appendix 3B 100902
01/09/2010

Preliminary Final Report
31/08/2010

ADO Research Note published
12/08/2010

Appendix 3B 100802
01/08/2010

Appendix 4C - quarterly
30/07/2010

Appendix 3B 100720
19/07/2010

Announces agreed terms with Merck
14/07/2010

Trading Halt
12/07/2010

Appendix 3B 100624
23/06/2010

Response to ASX Price Query
09/06/2010

Change of Director's Interest Notice 100526
26/05/2010

Appendix 3B 100518
17/05/2010

Appendix 4C - quarterly 100430
30/04/2010

Appendix 3B 100430
30/04/2010

Appendix 3B 100412
12/04/2010

Appendix 3B 100325
24/03/2010

Appendix 3Y 100316
16/03/2010

Appendix 3B 100316
16/03/2010

Appendix 3B 100309
09/03/2010

Bangs Laboratories Inc move into production with M
04/03/2010

Half Yearly Report and Accounts
26/02/2010

Appendix 3B 100225
24/02/2010

Appendix 3B 100215
15/02/2010

Section 708A(5)(e) Notice
11/02/2010

Appendix 3B 100209
09/02/2010

Ceasing to be a substantial holder
08/02/2010

Appendix 3B 10202
02/02/2010

Appendix 3B 100201
31/01/2010

s708A(5)(e) Notice 100129
29/01/2010

Boardroom Radio Interview with Dr Geoff Cumming
28/01/2010

Appendix 4C - quarterly 100127
27/01/2010

Ceasing to be a substantial holder 100127
27/01/2010

Change of Director's Interest Notice 100127
27/01/2010

Appendix 3B 100125
25/01/2010

EGM Results
22/01/2010

Change in substantial holding
22/01/2010

EGM Presentation
22/01/2010

Appendix 3B 100121
21/01/2010

Change of Director's Interest Notice
18/01/2010

Notice of Meeting EGM
14/01/2010

ADO Signs Licensing Agreement
13/01/2010

Becoming a substantial holder
08/12/2009

2009 AGM Results
23/11/2009

2009 AGM Presentation
23/11/2009

Change in substantial holding
16/11/2009

Change in substantial holding
16/11/2009

Section 708A(5)(e)
13/11/2009

Appendix 3B
09/11/2009

Entitlement Issue Shortfall Shares Allotted
09/11/2009

Change in substantial holding
04/11/2009

Entitlement Issue Applications Allotted
28/10/2009

Distribution Schedule Fully Paid Ordinary
28/10/2009

Distribution Scheduled Options
28/10/2009

Top 20 Options
28/10/2009

Appendix 4C - quarterly 091028
28/10/2009

Top 20 Fully Paid Ordinary Shares
28/10/2009

Entitlement Issue Closes
21/10/2009

Final NOM AGM 2009
20/10/2009

2009 AGM - Notice of Meeting
20/10/2009

2009 Annual Financial Report
30/09/2009

Supplementary Prospectus
29/09/2009

Replacement Entitlement Issue Document
21/09/2009

Replacement Entitlement Issue Document
21/09/2009

Letter to Optionholders
21/09/2009

Letter to Shareholders
21/09/2009

Entitlement Issue Prospectus
18/09/2009

Change of Director's Interest Notice
17/09/2009

Change in substantial holding
17/09/2009

Appendix 3B
14/09/2009

Resignation of Director
28/08/2009

Anteo signs co-operation and licence agreement
20/08/2009

Appendix 3B - Rights Issue 090918
18/08/2009

Appendix 4C - quarterly 090729
29/07/2009

Anteo enters commercial discussion 090729
29/07/2009

Change of Director's Interest Notice 090626
26/05/2009

Change of Director's Interest Notice 090601
01/05/2009

Change of Director's Interest Notice 090601
01/05/2009

Appendix 4C - quarterly Apr 09
29/04/2009

Change of Director's Interest Notice
24/04/2009

Change of Director's Interest Notice
14/04/2009

Initial Director's Interest Notice
09/04/2009

Ceasing to be a substantial holder
09/04/2009

Appointment of Director and Operations Update
09/04/2009

Half Yearly Report and Accounts
26/02/2009

Change in substantial holding
30/01/2009

Appendix 4C Dec 2008
30/01/2009

Form 604 - Notice of change or interests
30/01/2009

Anteo CEO Appointment
30/01/2009

Revenue and Royalty Agreement NZDX
21/01/2009

Terms of Access, Privacy, © 2008 Anteo diagnostics Website by JOiE Creative